Metformin in cardiac surgery: high expectations

Lancet Diabetes Endocrinol. 2015 Aug;3(8):581-2. doi: 10.1016/S2213-8587(15)00209-0. Epub 2015 Jul 12.

Authors

Iwan C C van der Horst¹, Maarten W N Nijsten²

Affiliations

¹ Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands. Electronic address: i.c.c.van.der.horst@umcg.nl.
² Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.

PMID: 26179505
DOI: 10.1016/S2213-8587(15)00209-0

No abstract available

Publication types

Comment

MeSH terms

Coronary Artery Bypass / adverse effects*
Female
Heart Injuries / prevention & control*
Humans
Hypoglycemic Agents / therapeutic use*
Intraoperative Complications / drug therapy*
Male
Metformin / therapeutic use*

Substances

Hypoglycemic Agents
Metformin